Pregnancy Outcomes in Women with Homozygous Beta Thalassaemia: A Single-centre Experience from Oman

Overview

Journal Sultan Qaboos Univ Med J

Specialty General Medicine

Date 2014 Aug 7

PMID 25097768

Citations 3

Authors

Nihal Al-Riyami

Maha Al-Khaduri

Shahina Daar

Affiliations

Soon will be listed here.

Abstract

Objectives: Pregnancy in women with homozygous beta thalassaemia (HBT) carries a high risk to both the mother and fetus. The aim of this study was to investigate pregnancy outcomes among this group at a single tertiary centre.

Methods: This retrospective descriptive study was conducted between January 2006 and December 2012 on all women with HBT who received prenatal care and subsequently delivered at Sultan Qaboos University Hospital, Muscat, Oman. Women who delivered elsewhere and women with the beta thalassaemia trait were excluded.

Results: Ten women with HBT were studied with a total of 15 pregnancies and 14 live births. The mean maternal age ± standard deviation (SD) was 27.9 ± 3.7 years, with a range of 24-35 years. There were 14 spontaneous pregnancies and one pregnancy following hormone treatment. Eight women had been on chelation therapy before pregnancy, one of whom needed chelation during late pregnancy. Of the pregnancies, 93% had a successful outcome with a mean ± SD gestational age at delivery of 38.6 ± 0.9 weeks, with a range of 37-40 weeks. Eight babies (57%) were delivered by Caesarean section. The mean ± SD birth weight was 2.6 ± 0.2 kg, with a range of 1.9-3.0 kg. Three babies (21%) were born with low birth weights.

Conclusion: Pregnancy is safe and usually has a favourable outcome in patients with HBT, provided that a multidisciplinary team is available. This is the first study of Omani patients with HBT whose pregnancies have resulted in a successful outcome.

Citing Articles

Pregnancy outcome in women with transfused beta-thalassemia in France.

Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F Ann Hematol. 2021; 101(2):289-296.

PMID: 34668980 DOI: 10.1007/s00277-021-04697-4.

Pregnancy in Thalassemia.

Origa R, Comitini F Mediterr J Hematol Infect Dis. 2019; 11(1):e2019019.

PMID: 30858957 PMC: 6402552. DOI: 10.4084/MJHID.2019.019.

Re: Pregnancy Outcomes in Women with Homozygous Beta Thalassaemia: A single-centre experience from Oman.

Al-Mendalawi M Sultan Qaboos Univ Med J. 2015; 15(1):e148.

PMID: 25685379 PMC: 4318600.

References

Noetzli L, Carson S, Nord A, Coates T, Wood J . Longitudinal analysis of heart and liver iron in thalassemia major. Blood. 2008; 112(7):2973-8. PMC: 2556627. DOI: 10.1182/blood-2008-04-148767. View

Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini M, Del Vecchio G . Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89(10):1187-93. View

Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M . Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab. 1999; 11 Suppl 3:935-43. View

Singer S, Vichinsky E . Deferoxamine treatment during pregnancy: is it harmful?. Am J Hematol. 1999; 60(1):24-6. DOI: 10.1002/(sici)1096-8652(199901)60:1<24::aid-ajh5>3.0.co;2-c. View

Al-Riyami A, Suleiman A, Afifi M, Al-Lamki Z, Daar S . A community-based study of common hereditary blood disorders in Oman. East Mediterr Health J. 2004; 7(6):1004-11. View

Origa R, Piga A, Quarta G, Forni G, Longo F, Melpignano A . Pregnancy and beta-thalassemia: an Italian multicenter experience. Haematologica. 2009; 95(3):376-81. PMC: 2833066. DOI: 10.3324/haematol.2009.012393. View

Tsironi M, Ladis V, Margellis Z, Deftereos S, Kattamis C, Aessopos A . Impairment of cardiac function in a successful full-term pregnancy in a homozygous beta-thalassemia major: does chelation have a positive role?. Eur J Obstet Gynecol Reprod Biol. 2005; 120(1):117-8. DOI: 10.1016/j.ejogrb.2004.08.005. View

Leung T, Lao T . Thalassaemia in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011; 26(1):37-51. DOI: 10.1016/j.bpobgyn.2011.10.009. View

Tsironi M, Karagiorga M, Aessopos A . Iron overload, cardiac and other factors affecting pregnancy in thalassemia major. Hemoglobin. 2010; 34(3):240-50. DOI: 10.3109/03630269.2010.485004. View

10.

Telfer P, Coen P, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E . Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica. 2006; 91(9):1187-92. View

11.

. Fertility in thalassemia: the Greek experience. J Pediatr Endocrinol Metab. 1999; 11 Suppl 3:945-51. View

12.

Bajoria R, Chatterjee R . Current perspectives of fertility and pregnancy in thalassemia. Hemoglobin. 2009; 33 Suppl 1:S131-5. DOI: 10.3109/03630260903365023. View

13.

Tuck S, Jensen C, Wonke B, Yardumian A . Pregnancy management and outcomes in women with thalassaemia major. J Pediatr Endocrinol Metab. 1999; 11 Suppl 3:923-8. View

14.

Vini D, Servos P, Drosou M . Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®). Eur J Haematol. 2011; 86(3):274-5. PMC: 3123701. DOI: 10.1111/j.1600-0609.2010.01569.x. View

15.

Modell B, Khan M, Darlison M, Westwood M, Ingram D, Pennell D . Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008; 10:42. PMC: 2563008. DOI: 10.1186/1532-429X-10-42. View

16.

Nassar A, Naja M, Cesaretti C, Eprassi B, Cappellini M, Taher A . Pregnancy outcome in patients with beta-thalassemia intermedia at two tertiary care centers, in Beirut and Milan. Haematologica. 2008; 93(10):1586-7. DOI: 10.3324/haematol.13152. View

17.

Farmaki K, Gotsis E, Tzoumari I, Berdoukas V . Rapid iron loading in a pregnant woman with transfusion-dependent thalassemia after brief cessation of iron chelation therapy. Eur J Haematol. 2008; 81(2):157-9. PMC: 2607536. DOI: 10.1111/j.1600-0609.2008.01092.x. View

18.

Mandruzzato G, Antsaklis A, Botet F, Chervenak F, Figueras F, Grunebaum A . Intrauterine restriction (IUGR). J Perinat Med. 2008; 36(4):277-81. DOI: 10.1515/JPM.2008.050. View

19.

Cunningham M . Update on thalassemia: clinical care and complications. Pediatr Clin North Am. 2008; 55(2):447-60, ix. DOI: 10.1016/j.pcl.2008.02.002. View

20.

Alkindi S, Al Zadjali S, Al Madhani A, Daar S, Al Haddabi H, Al Abri Q . Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin. 2010; 34(2):135-44. DOI: 10.3109/03630261003677213. View